JournalsHub
.online
Find My Journal
VL

Véronique Leblond

Sorbonne Université FR

ORCID 0000-0001-9974-8868
392
Publications
14,749
Citations
62
H-Index
187
i10-Index
6.6
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

A. Quinquenel, R. Letestu, M. Le Garff-Tavernier, Stéphane Morisset, F. Subtil - EClinicalMedicine, 2025
Cited by 1 Semantic Scholar

EE681 Economic Impact of Fixed-Treatment Duration for Chronic Lymphocytic Leukemia: Budget-Impact Analysis of Venetoclax Plus Obinutuzumab for First Line Treatment of Unfit Patients in France

V. Leblond, C. Souihi, J. Ramier, B. Manzoor, S. Leprêtre - Value in Health, 2023
Cited by 0 Semantic Scholar

Research Topics

Chronic Lymphocytic Leukemia Research (246) Lymphoma Diagnosis and Treatment (181) Immunodeficiency and Autoimmune Disorders (90) Viral-associated cancers and disorders (57) Acute Lymphoblastic Leukemia research (35)

Affiliations

Hôpital Necker-Enfants Malades
FR 1998 - 1998
Centre National de la Recherche Scientifique
FR 2019 - 1994
Radboud University Nijmegen
NL 2014 - 2014
Inserm
FR 2019 - 1998
Université Paris Cité
FR 2018 - 2004

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now